Aurinia Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference
Aurinia Pharmaceuticals (NASDAQ: AUPH) announced that its executive management will participate in a fireside chat at the Jefferies Virtual Healthcare Conference on June 3, 2021, at 11:30 a.m. ET. Interested parties can access the live audio webcast via the 'News/Events' section on the Aurinia corporate website. A playback of the event will also be available after the live session. Aurinia focuses on therapies for serious diseases with high unmet needs and has developed LUPKYNIS™ (voclosporin), the first FDA-approved oral treatment for adult patients with active lupus nephritis.
- None.
- None.
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (the “Company”) today announced that members of the executive management team will participate in a fireside chat during the Jefferies Virtual Healthcare Conference on Thursday, June 3, 2021 at 11:30 a.m. ET.
In order to participate in the audio webcast, interested parties can access the live webcast under "News/Events” through the “Investors” section of the Aurinia corporate website at www.auriniapharma.com. A replay of the webcast will be available on Aurinia’s website.
ABOUT AURINIA
Aurinia Pharmaceuticals is a fully integrated biopharmaceutical company focused on delivering therapies to treat targeted patient populations that are impacted by serious diseases with a high unmet medical need. The Company has introduced LUPKYNIS™ (voclosporin), the first FDA-approved oral therapy dedicated for the treatment of adult patients with active lupus nephritis (LN). The Company’s head office is in Victoria, British Columbia, its U.S. commercial hub is in Rockville, Maryland, and the Company focuses its development efforts globally.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210527005326/en/
FAQ
When is Aurinia Pharmaceuticals participating in the Jefferies Virtual Healthcare Conference?
How can I access the Aurinia Pharmaceuticals webcast?
What is LUPKYNIS™ by Aurinia Pharmaceuticals?
Where is Aurinia Pharmaceuticals based?
